Company intelligence / Profile preview

Nanjing Bluegene Biotech

Shanghai, Shanghai, Chinaelisakit.cc ↗

Ownership: Private
Development stage: Commercial

Overview

BlueGene Biotech is an established manufacturer of ELISA kits, recombinant proteins, antibodies, and plasmids for life science research. It serves global academic and industrial customers with thousands of products covering areas such as cancer, immunology, metabolism, cell biology, neurobiology, microbiology, cardiovascular disease, and signal transduction[1][2][5].

Modalities: Recombinant proteinAntibodyPlasmid vector
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Nanjing Bluegene Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanjing Bluegene Biotech.

Explore the full profile